Decreased number of cilia in partially formed KV lumen. by Jeong-gyun Kim (4330168)

Rh-endostatin decreases microvascular density (MVD) and promotes vessel normalization of A549 lung carcinoma. by Shujing Shi (422263)

Decreased fibrin deposition in hypoxic C3−/− mice. by Eileen M. Bauer (337320)

Senescent endothelial cells of hippocampus are decreased by treatment with DHT. by Hidetaka Ota (189433)

Dex treatemnt decreases body and muscle weight in mice. by Yanjun Dong (389082)

Imatinib decreases <i>in vivo</i> proliferation of T-cells. by Ludovic Belle (293091)

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

CCN3 protein decreases β-cell proliferation. by Renée Paradis (326111)

HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

“…(<b>E</b>) Low and high magnification views of pericardial nephrocytes (dotted outlines) from STD and HFD larvae, showing that HFD decreases mitochondria (marked with anti-ATP5A) and ER (marked with anti-KDEL) but increases LDs (marked with LipidTOX). …”

FLZ decreased the expression of phospho-APP and APP-CTF. by Xiu-Qi Bao (479278)

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…At each interval, we obtained (<b>A</b>) microscopic images (original magnification: 100x), (<b>B</b>) AFM topography images (scan size <b>B1</b>, 50 µm; <b>B2</b>, 20 µm; <b>B3</b>, 33.3 µm), and (<b>C</b>) height measurements at the cross section of an individual cell. …”

MβCD treatment decreases neuroglian stabilization. by Nicholas J. Gibson (173220)

Chemotherapy decreases cell proliferation in the adult mouse CNS by Joerg Dietrich (35101)

Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

“…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”

2-NBDG₆₀ is sensitive to a decrease in blood glucose levels. by Narasimhan Rajaram (474255)

“…<p><b>A</b>. Representative 2-NBDG kinetic profiles for 3 different fasting groups of mice after injection of a 6 mM (2mg/ml) dose via the tail-vein. …”

Hepatosomatic index % (a); Spleen somatic index % (b) in tilapia in different experimental groups. by Sinthia Kabir Mumu (17705902)

Subjects:

Loss of Sidt2 decreased insulin granule exocytosis. by Jialin Gao (420257)

Healthspan decreases in response to cell-associated factor LPS in a dose-dependent manner. by Gabriel M. Moore (8566113)

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

“…Two of the five siRNAs tested were found to efficiently inhibit mRNA of both <i>TMPRSS2-ERG</i> variants and to decrease ERG protein expression. …”

Conditional ablation of <i>Ybx1</i> leads to a reduction in cortical progenitor cell pool and a decrease in cortical thickness. by Jian Zhang (1682)